Jan 7, 2025 · Children ages 5–11 years. Your child is up to date when they have received: 1 dose of the 2024–2025 Moderna COVID-19 vaccine OR. 1 dose of the 2024–2025 Pfizer-BioNTech COVID-19 vaccine.

October 23, 2024 - Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose. These updated recommendations also allow for …

Apr 25, 2024 · In addition, in a large cohort of nursing home residents during circulation of SARS-CoV-2 Omicron subvariants, receipt of a second original monovalent mRNA COVID-19 booster dose ≤60 days earlier was 74% effective against severe COVID-19–related outcomes (including hospitalization or death) and 90% effective against death, compared with ...

Having a booster seat law that covers child passengers until at least age 9 is one of the most effective strategies for increasing booster seat use and reducing motor vehicle-related injuries and deaths among children.

Booster seats are an important stage of child passenger safety because they elevate and position a child so that the seat belt’s lap and shoulder belts it properly.

Nov 19, 2021 · The Food and Drug Administration’s (FDA) authorization and CDC’s recommendation for use are critical next steps forward in our country’s booster program – a program which will help provide increased protection against COVID-19 disease and death.

Jul 24, 2024 · For Hib vaccines, any monovalent or combination conjugate vaccine is acceptable for the booster dose of the series, if only one product was used for the primary series 56.

Nov 21, 2024 · The 2025 Immunization Schedules approved by ACIP and adopted by the CDC Director on October 24, 2024 are now available below.

Jan 31, 2025 · A "booster" dose is an extra dose of vaccine that can increase or extend the effectiveness of the vaccine. Most healthy people do not need a booster dose.

CDC recommends a booster dose for these individuals if a year or more has passed since the most recent MenB vaccine. There are also outbreak situations when public health authorities may recommend a booster dose after 6 months have passed since the most recent MenB vaccine.